Identification of Psychoactive Substance Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department
DRUGS
Systematic Screening and Identification of Psychoactive Substances Users in Young Adults (16 to 25 Years Old) Visiting the Emergency Department
1 other identifier
observational
459
1 country
1
Brief Summary
Adolescence is a time for great physical and psychological change and it's often at that period of life that first use of psychoactive substances occurs. Although addiction is rare in teenagers, psychoactive substances abuse can have serious long-term health consequences on them. This is therefore a priority for all healthcare providers to identify early use and abuse of drugs in the youth's population. The addictive process underlies environmental, genetic and individual causes. That is why it is somehow possible to identify individuals at risk based on some common sociological, cultural and environmental risk factors. Due to the acute consequences of psychoactive substances abuses, Emergency Departments are main checkpoints for the screening of young drug users. Indeed, one patient out of five admitted in an Emergency Department shows a positive blood alcohol concentration regardless of the reason for their admission. This rate is twice as high as in the overall population. Hence, Emergency Departments are at the front-line for screening, caring, referral and transfer of psychoactive substances users. That is why the Emergency Department is the best place for this study. In 2004, the special consultations of young consumers were founded in order to deal with these special cases where dependence is not yet established or installed and care has to be adapted to the age. Offering help to this age range represents a real challenge since only 20% of the teenagers come to visit this special consultations on their own initiative. The rest of teenagers are either obliged by their parents or sentenced by a court. The investigators assume that the repetition of care offered to the teenagers by repeated emergency admissions could trigger their own desire to overcome their drug use disorders and visit the Addictionology Department.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2019
CompletedFirst Posted
Study publicly available on registry
November 22, 2019
CompletedStudy Start
First participant enrolled
February 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2021
CompletedApril 26, 2021
April 1, 2021
1.2 years
November 15, 2019
April 23, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Consumption questionnaire and urinary strips to detect psychoactive substances users
The primary objective of the study is to evaluate the prevalence of psychoactive substances use among young adults, aged 16 to 25, visiting the Emergency Department. This evaluation will be twofold: * declarative through a consumption questionnaire (response by Yes or No without score) (whole life, past three months and previous month) * analytical by means of a urinary screening for recent consumptions (from a few days to a few weeks according to the products) of seven psychoactive substances (Alcohol, tobacco, cannabis, ecstasy, amphetamines, cocaine, morphinics).
Follow-up time: 3 months
Eligibility Criteria
Young people aged 16-25 inclusive, admitted to the Medical and Psychiatric Emergency Department (Building N) of the Edouard Herriot Hospital.
You may qualify if:
- All patients aged 16 to 25 admitted at the Medical and Psychiatric Emergency Department.
- For adults: those who will agree to participate in this study
- For Minors from the age of 16: those who will agree to participate and want to exercise their rights by themselves or for whom one parent or legal guardian agrees for their participation.
You may not qualify if:
- patient who doesn't understand French
- patient under legal protection measures or guardianship
- confused person (GSC \< 15)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Edouard Herriot
Lyon, 69003, France
Biospecimen
Urinary strips will determine the recent consumptions (from a few days to a few weeks according to the products) of seven psychoactive substances (alcohol, tobacco, cannabis, ecstasy, amphetamines, cocaine, morphinics). The detection of some substances in urine works via measurement of the decomposition products from metabolism: cotinine for tobacco, ethyl glucuronide for alcohol, benzoylecgonine for cocaine. Regarding ecstasy, amphetamines, cannabis and morphinics, the detection is done directly in urines. There are seven reading windows (one for each substance) on the Drug Screen: if a colored strip appears in the reading window it means that the detection is negative, otherwise if there is no strip it is considered as positive
Study Officials
- PRINCIPAL INVESTIGATOR
Aurélie BERGER-VERGIAT, MD
Service Addictologie et Psychiatrie des urgences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2019
First Posted
November 22, 2019
Study Start
February 11, 2020
Primary Completion
April 15, 2021
Study Completion
April 15, 2021
Last Updated
April 26, 2021
Record last verified: 2021-04